Novartis Investigative Site

Shreveport, Louisiana 71101

Use our guide to learn which trials are right for you!

We've found
8 trials
at this facility
Spondylitis, Ankylosing Clinical Trial
16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis
Status: Enrolling, Phase III
Updated: 1/6/2016
mi
from
Shreveport, LA
Click here to add this to my saved trials
Non-Hodgkin's Lymphoma Clinical Trial
Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy
Status: Enrolling, Phase III
Updated: 3/22/2016
mi
from
Shreveport, LA
Click here to add this to my saved trials
Atherosclerosis Clinical Trial
Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Shreveport, LA
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis
Status: Enrolling, Phase III
Updated: 3/25/2016
mi
from
Shreveport, LA
Click here to add this to my saved trials
Persistent Asthma Clinical Trial
Study of Safety of Foradil in Patients With Persistent Asthma
Status: Enrolling, Phase IV
Updated: 4/4/2016
mi
from
Shreveport, LA
Click here to add this to my saved trials
Carcinoma, Renal Cell Clinical Trial
Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 3/22/2016
mi
from
Shreveport, LA
Click here to add this to my saved trials
Arthritis, Psoriatic Clinical Trial
16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic Arthritis
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Shreveport, LA
Click here to add this to my saved trials
Hepatitis C, Chronic Clinical Trial
Efficacy and Safety Study of DEB025/Alisporivir Combined to Peg-IFN and Ribavirin in Chronic Hepatitis C Genotype 1 Treatment-naïve Patients
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Shreveport, LA
Click here to add this to my saved trials